Peoples Financial Services Corp. Novartis Ag Transaction History

Peoples Financial Services Corp.

$214 Million
Q4 2024

A detailed history of Peoples Financial Services Corp. transactions in Novartis Ag stock. As of the latest transaction made, Peoples Financial Services Corp. holds 2,084 shares of NVS stock, worth $208,337. This represents 0.09% of its overall portfolio holdings.

Number of Shares

2,084

Previous 2,357 11.58%

Holding current value

$208,337

Previous $271,000 25.46%

% of portfolio

0.09%

Previous 0.12%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 14, 2025	SELL	$96.78 - $117.18 $26,420 - $31,990	-273 Reduced 11.58%	2,084 $202,000
Q3 2024 Oct 16, 2024	SELL	$106.13 - $120.89 $4,245 - $4,835	-40 Reduced 1.67%	2,357 $271,000
Q2 2024 Jul 25, 2024	SELL	$92.57 - $107.37 $9,812 - $11,381	-106 Reduced 4.23%	2,397 $255,000
Q1 2024 Apr 17, 2024	SELL	$95.27 - $108.47 $21,340 - $24,297	-224 Reduced 8.21%	2,503 $242,000
Q3 2023 Oct 13, 2023	SELL	$94.73 - $105.13 $189 - $210	-2 Reduced 0.07%	2,727 $277,000
Q1 2023 Apr 13, 2023	SELL	$80.03 - $92.81 $27,770 - $32,205	-347 Reduced 11.28%	2,729 $251,000
Q1 2022 Apr 15, 2022	SELL	$80.11 - $90.62 $16,022 - $18,124	-200 Reduced 6.11%	3,076 $270,000
Q3 2021 Oct 15, 2021	SELL	$81.78 - $95.14 $12,267 - $14,271	-150 Reduced 4.38%	3,276 $268,000
Q3 2019 Oct 16, 2019	SELL	$85.54 - $94.26 $4,277 - $4,713	-50 Reduced 1.44%	3,426 $298,000
Q3 2018 Oct 12, 2018	SELL	$66.94 - $77.43 $33,470 - $38,715	-500 Reduced 12.58%	3,476 $299,000
Q1 2018 Apr 25, 2018	SELL	$70.39 - $84.15 $10,276 - $12,285	-146 Reduced 3.54%	3,976 $322,000
Q3 2017 Oct 18, 2017	BUY	$74.14 - $77.27 $305,605 - $318,506	4,122	4,122 $354,000

Others Institutions Holding NVS

# of Institutions

1,423

Shares Held

130M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $215B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peoples Financial Services Corp., based on Form 13F filings with the SEC.

News

Stay updated on Peoples Financial Services Corp. with notifications on news.

Account

Peoples Financial Services Corp. Novartis Ag Transaction History